In this episode of the podcast, Joe Moore interviews Kathryn L. Tucker, JD: Special Counsel at Emerge Law Group, where she Co-Chairs the Psychedelic Practice Group. Tucker has had a 35-year career in advocacy and protecting rights of terminally ill patients, serving as lead counsel in three landmark federal cases around constitutional rights and dying. Most recently, she was part of the team responsible for enacting Oregon’s groundbreaking Measure 109. She discusses the mechanics of how access to psychedelic medicine works under Right to Try; how she feels about decriminalization vs. legalization and how it all relates to what she’s seen in the field of death and dying; what she’s excited about in Oregon; and how measures in Colorado could take things even further. It’s been over a year with no answer on how the DEA would be enabling psilocybin access to patients under the Right to Try act, so she invites activists everywhere to shine the bright light of public scrutiny on the insulting inaction of perhaps the government’s most ineffective agency. There’s a clear path here where everyone wins, so please, call your state’s elected officials and demand that they actually do their job.

The post PT307 – Kathryn L. Tucker, JD – The Right to Try Act and the Battle for Psilocybin Access appeared first on Psychedelics Today.

Previous articleHealth Canada Approves First Special Access Program Requests for Psilocybin
Next articleEntheon Biomedical Announces Non-Brokered Private Placement Financing